Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.
Hepatic fibrosis: are any of the serum markers useful?
Can serum markers be used to reliably detect liver fibrosis?
Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis.
Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States.
Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C.
Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.
Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience.